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Setting: Pediatric cardiology outpatient department
at Prince Sultan Cardiac Center – Qassim.
Patients: Parents of 71 randomly selected children
with CHD of different severity.
Main outcome measures: The social impact on fam-
ily score.
Methods: The impact on family questionnaire of
Stein and Riessman was instituted. This questionnaire,
which determines the effects of a chronic illness on par-
ents and families, has been used to assess the impact of
CHD. It is based on four subscales assessing perceived
(1) financial burden; (2) familial/social impact; (3) per-
sonal strain; and (4) mastery. The first subscale contains
four statements. The second subscale contains nine state-
ments assessing social effects of CHD. The third subscale
has six statements relating to the personal stress imposed
by CHD on the parent. The third subscale has six state-
ments relating to the personal stress imposed by CHD
on the parent. The final subscale contains positively
phrased statements to assess the positive effects of the
child’s CHD on the parent’s feelings of control in his or
her life. The parent’s response is given as a number from
1 to 4, where 1 represents strong agreement, 2 predomi-
nant agreement, 3 weak partial agreement, and 4 strong
disagreement. The fourth subscale is reverse coded, so
that it is compatible with the other subscales to calculate
a final score where a low score corresponds to a high
impact. This score is then inverted so that a high score
is equivalent to a high impact. The questionnaire was
administered by a two Researchers. Patients were
divided into three groups according to the severity of
the CHD they do have (Mild, Moderate and Sever). Mild
CHD was defined as any CHD with no need for medical
or surgical management. Moderate CHD was defined as
a CHD which required surgical or cath intervention.
Severe CHD was defined as CHD with single ventricle
physiology who underwent Glenn or Fontan procedure,
as well as patients with dilated CMP taking more than
two cardiovascular medications. The mean impact on
family scores was compared among the different groups
by two sample t test analysis.
Results: Families of 71 children with severe CHD
were interrogated. The main age was 3.76 ± 3 years. 23
were males (32.4%) and 48 (67.6%) were females. Mild
CHD constitute 36.6%, moderate 29.6% and severe 33.8%.
Families of children with severe CHD had a signifi-
cantly higher impact on family score (mean of 62) than
families with mild and moderate CHD (mean of 48) P
value > .005.
Conclusion: Families of patients with severe CHD
have significant social impact because of their child ill-
ness. Supporting public groups in Saudi Arabia should
be initiated and encouraged.
http://dx.doi:10.1016/j.jsha.2012.06.213
Active fixation pacing leads in the distal coronary
venous system in patients with prosthetic tricus-
pid valve
Ahmad Fazli Abdul Aziz, Azlan Hussin, Surinder
Kaur, Tay Giat Sing, Zunida Ali, Noor Asyikin
Sahat, Razali Omar
Introduction: Permanent pacemaker implantations
in patients requiring ventricular pacing is usually accom-
plished by the placement of endocardial pacing lead in
the right ventricle. In the presence of prothestic tricuspid
valve, this method has the potential of causing complica-
tions to the lead or the prosthetic valve and thus not rec-
ommended. Pacing options for this group of patients
include epicardial lead implantation or the placement
of lead in the coronary sinus. We describe the use of
active fixation lead mechanism in the coronary sinus to
improve stability in this group of patients.
Methods: Between July 2010 until September 2011, we
implanted 4F active fixation leads (SelectSecure Model
3830, Medtronic, Minneapolis, MN, USA) in three patients
with prosthetic tricuspid valve who required ventricular
pacing. Active fixation leads were used in view of lead
instability with conventional coronary sinus pacing leads.
The lead was positioned and actively fixed at its optimal at
the distal coronary sinus. The performances of the leads
and its related complications were then monitored.
Results: The leads were successfully implanted in all
three patients. The peri implantation pacing parameters
were within acceptable limits with pacing thresholds of
2.3, 1.2 and 0.5 V, respectively and pacing impedances
of 1450, 817 and 1384X. Follow up interrogation revealed
stable pacing parameters. No immediate complications
were observed.
Conclusion: A 4F active fixation lead placement at
the distal coronary sinus to deliver left ventricular stimu-
lation in patients with prosthetic tricuspid valve showed
stable and consistent delivery of acceptable pacing
performances.
http://dx.doi:10.1016/j.jsha.2012.06.214
Assessment of left ventricular geometry, functions
and mass in patients with metabolic syndrome
Ahmed M. Sanad, Azza Z. El-Eraky, Mohamed A.
Oraby, Hanan M. Kamal
Background and aims: The frequent coexistence of
obesity, arterial hypertension, and lipid and carbohy-
drate disorders is well known. Although these conditions
have been identified as independent risk factors for
impaired left ventricular diastolic function, there is a
paucity of data on the dysfunction among patients with
metabolic syndrome (MS). The aim of this study was to
determine the impact of metabolic syndrome on left ven-
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tricular systolic and diastolic functions, mass and geome-
try by using conventional echocardiography and pulsed
wave tissue Doppler imaging in individuals with MS
compared to healthy subjects.
Methods: The study included 120 subjects divided
by half into control and case group: 60 subjects (30 males
and 20 females) with MS (diagnosed according to consen-
sus statement from the International Diabetes Federation
(platinum standard)) aged 54.4 ± 9.5 years and 60 healthy
subjects (32 males and 28 females) aged 50.3 ± 13.7 years.
Left ventricular ejection fraction (LVEF) was measured
with the Tiech method in the short axis parasternal view
by averaging measurements from five consecutive car-
diac cycles. The LV diastolic function was estimated with
Doppler measurement of transmitral blood flow and
determination of the maximal rates for E and A peaks,
E/A ratio, delay time (DT) for early diastolic filling rate,
E0, A0 and E0/A0 ratio according to criteria of the European
Study Group on diastolic heart failure. IMP was be calcu-
lated as the sum of IVRT and IVCT divided by ventricular
ET (IMP = IVRT + IVCT/ET). LV mass was determined
using the corrected cube formula as (0.80  {1.04  [(sep-
tal thickness + LV internal diameter + posterior wall
thickness)3  (LV internal diameter)3]} + 0.6).
Results: The assessed parameters using conven-
tional and tissue Doppler echocardiography showing that
those with metabolic syndrome had greater LV mass and
significantly lower E/A ratio; increased LVH and signifi-
cantly higher IMP, indicating impaired global left ven-
tricular functions in patients with MS compared with
control subjects without MS. There were no statistically
significant difference in EF percentage.
Conclusions: Our results demonstrate that LV func-
tions are impaired in patients with metabolic syndrome
using IMP and E/A ratio. LVH incidence are higher in
metabolic syndrome patients. To conclude metabolic syn-
drome are associated with significant cardiac functions
deterioration and should be prevented and treated in
proper manner.
http://dx.doi:10.1016/j.jsha.2012.06.215
HCV Cardiomyopathy; raising a regional alert
A. Saleh, A. Matsumori, H. Negm, M. Shalaby, M.
Haykal, W. Sayed
Introduction: The global prevalence of Hepatitis C
Virus ‘‘HCV’’ carriers is estimated to average 3%, ranging
from 0.1% toP10% among different countries, 17–30% of
them complain of HCV Cardiomyopathy.
Objectives: To raise regional awareness of HCV as a
cardiotropic virus through sharing four stages of our
HCV Cardiomyopathy research.
Methodology: Fifty HCV positive patients with 50
controls were enrolled in first stage where conventional
echocardiography was used to evaluate LV systolic and
diastolic function. Tissue Doppler imaging was used in
the second stage to evaluate 30 HCV patients and 30 con-
trols. Forty five HCV positive patients with 45 controls
were evaluated by Strain Rate Imaging to assess left atrial
tissue dynamics in addition to measuring NTproBNP. At
our fourth stage, we evaluated combined antiviral and
anti-inflammatory therapy in 13 patients complaining of
HCV Cardiomyopathy. Speckle tracking echocardiogra-
phy was our tool to assess myocardial function before
and after administration of therapy.
Results: HCV group showed significant increase in
QTc interval, significant increase in A wave, Deceleration
time in addition to highly significant decrease in tissue
DopplerEa, highly significant decrease inAa and highly sig-
nificant increased E/Ea ratio. Evaluation of Left atrial func-
tion revealed significant increase in left atrial ejection
fraction, ejection time, ejection force. Significant improve-
ment of global myocardial strain was showed after admin-
istration of therapy in patients with HCV Cardiomyopathy.
Conclusion: HCV is a cardiotropic virus. HCV
derived heart diseases are chronic and devastating dis-
eases. The combined anti-viral and anti-inflammatory
treatment may cure HCV derived cardiomyopathy.
http://dx.doi:10.1016/j.jsha.2012.06.216
Left main stenting, a short and intermediate fol-
low-up
A. Farah, M.-A. Ohlow, B. Lauer, A. Zaki, M.
Rashwan, M. Sobhy
Background: Significant left main coronary artery
disease occurs in about 5–7% of patients undergoing cor-
onary angiography. Coronary artery bypass graft (CABG)
surgery was the standard acceptable way in treating
these lesions. The introduction of drug eluting stents
(DES) in mid 2003 has pushed the rate of clinical resteno-
sis below 5% for most lesion types. This encourged the
cardiologists to treat the LMCA with DES.
Methods and results: We implanted DES in 30
patients with denovo LMCA-Stenosis (middle age
69.9 ± 12.5 83% men). 25 patients (83%) had hypertension,
5 diabetes mellitus (17%), 22 hyperlipidemia (73.3%) and
16 were smokers (53.3%). We implanted Paclitaxel-Stents
in 26 (87%) and 4 Sirolimus-Stents (13%). 11 patients
(37%) with Stents <16 mm. In 14 patients (47%) were dis-
tal LM (Bifurkation) and in 16 (53%) ostium or schaft.
Details of intervention technique (T-Stenting, V-Stenting,
Culotte and Y-Stenting) was left to the examiner. During
the followup (middle duration 6 months; range 4–
12 months) were no myocardial infarctions, Stent throm-
bose or death documented. In 4 patients (13.3%) was a
re-revascularisation procedure mandatory (1 CABG, 3
re-interventionen), without significant difference between
distal or non-distal lesions, type or lenght of stent.
Conclusion: LMCA intervention is in the hands of
experienced interventionalist technically possible and
sure (without MACE), connected with an accepted rate
of re-intervention.
http://dx.doi:10.1016/j.jsha.2012.06.217
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